Inactive Instrument
Janel Corporation Stock Other OTC
Stocks
JANL
US47077R1095
Pharmaceuticals
OTC Markets Traded| Market Cap | 60.29M 52.07M 48.93M 44.5M 83.67M 5.77B 85.05M 573M 224M 2.89B 226M 221M 9.59B | P/E 2024 |
225x | P/E 2025 | 8.64x |
|---|---|---|---|---|---|
| Enterprise Value | 67.91M 58.65M 55.11M 50.12M 94.24M 6.49B 95.79M 646M 252M 3.25B 255M 249M 10.81B | EV / Sales 2024 |
0.46x | EV / Sales 2025 | 0.24x |
| Free-Float |
17.08% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +16.67% |
| Manager | Title | Age | Since |
|---|---|---|---|
Darren Seirer
CEO | Chief Executive Officer | 52 | 2022-12-31 |
Nathan Shandy
DFI | Director of Finance/CFO | 39 | 2025-08-01 |
| Chief Executive Officer | 52 | 2014-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 77 | 2015-11-17 | |
John Gonzalez
BRD | Director/Board Member | 76 | 2016-05-31 |
Gregory Melsen
BRD | Director/Board Member | 74 | 2018-01-01 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +16.67% | -.--% | - | - | 60.29M | ||
| -0.31% | +2.44% | +41.97% | -0.61% | 80.48B | ||
| -1.02% | +2.25% | -3.19% | +25.69% | 51.06B | ||
| -3.10% | -5.64% | +11.56% | +158.84% | 48.19B | ||
| -0.74% | +3.13% | -49.36% | -48.70% | 46.5B | ||
| -0.39% | +0.91% | +55.50% | -23.07% | 31.12B | ||
| -0.52% | +7.01% | +137.24% | -36.68% | 25.41B | ||
| -0.30% | -0.33% | +39.46% | +84.18% | 24.43B | ||
| -1.42% | +3.13% | -1.26% | +182.96% | 21.11B | ||
| -1.83% | -1.21% | +59.91% | +107.34% | 16.28B | ||
| Average | +0.63% | +3.52% | +32.43% | +50.00% | 38.29B | |
| Weighted average by Cap. | -1.08% | +2.96% | +24.97% | +36.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 183M 158M 149M 135M 254M 17.52B 258M 1.74B 681M 8.77B 688M 673M 29.15B | 207M 179M 168M 153M 288M 19.84B 293M 1.97B 771M 9.93B 779M 762M 33.01B |
| Net income | 551K 476K 447K 407K 765K 52.69M 777K 5.24M 2.05M 26.38M 2.07M 2.02M 87.68M | 5.66M 4.89M 4.59M 4.18M 7.85M 541M 7.98M 53.8M 21.03M 271M 21.24M 20.78M 900M |
| Net Debt | 36.99M 31.95M 30.02M 27.3M 51.33M 3.54B 52.18M 352M 138M 1.77B 139M 136M 5.89B | 7.62M 6.58M 6.18M 5.62M 10.57M 728M 10.74M 72.43M 28.32M 365M 28.59M 27.97M 1.21B |
Employees
-
Sector
Pharmaceuticals
















